You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Rb antibody (ab6075)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab6075? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab6075 has been referenced in 8 publications.

  1. Sullivan LL et al. Genomic size of CENP-A domain is proportional to total alpha satellite array size at human centromeres and expands in cancer cells. Chromosome Res 19:457-70 (2011). WB. PubMed: 21484447
  2. Kim A et al. Enhanced expression of mitochondrial superoxide dismutase leads to prolonged in vivo cell cycle progression and up-regulation of mitochondrial thioredoxin. Free Radic Biol Med 48:1501-12 (2010). PubMed: 20188820
  3. Regad T et al. The tumor suppressor Pml regulates cell fate in the developing neocortex. Nat Neurosci 12:132-40 (2009). ICC/IF, IHC-P; Mouse. PubMed: 19136970
  4. Kisielewska J et al. MAP kinase dependent cyclinE/cdk2 activity promotes DNA replication in early sea urchin embryos. Dev Biol 334:383-94 (2009). WB; Sea Urchin. PubMed: 19665013
  5. Finn RS et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res 11:R77 (2009). WB; Human. PubMed: 19874578
  6. Miao D et al. Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein. Proc Natl Acad Sci U S A 105:20309-14 (2008). WB; Mouse. PubMed: 19091948
  7. Donapaty S et al. RRR-alpha-tocopherol succinate down-regulates oncogenic Ras signaling. Mol Cancer Ther 5:309-16 (2006). PubMed: 16505104
  8. Slawson C et al. Perturbations in O-GlcNAc protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem : (2005). PubMed: 16027160

Publishing research using ab6075? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"